Clinical Trial

Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants

Study acronym: STEROID

Terminated Phase 2

View on ClinicalTrials.gov →

Why the trial stopped

low recruitment

Summary

This prospective, virtually administered trial conducted throughout the United States aims to evaluate a standardized protocol including the serial dilution of topical decongestants with concurrent topical steroids (triamcinolone), for elimination of dependence on topical decongestants.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2025-09-03; most recent amendment 2026-03-19.

Status change: Recruiting → Terminated 2026-03-19

Trial Details

NCT Number	NCT07168148
Lead Sponsor	Washington University School of Medicine
Conditions	Nasal Obstruction, Chronic Rhinitis
Enrollment	3 participants
Start Date	2025-11-10
Primary Completion	2026-03-19 (estimated)
Study Completion	2026-03-19 (estimated)
Updated on ClinicalTrials.gov	2026-03-23